NCT03923296View on ClinicalTrials.gov

PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy.

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

July 16, 2021

Study Completion Date

July 16, 2021

Conditions

Cancer

Interventions

DEVICE

Blood measurement and monitoring

Blood from a single fingerprick will be used to used to measure and monitor patients blood parameters.

BEHAVIORAL

Interviews

Focus group interviews

Trial Locations (1)

M20 4BX

The Christie NHS Foundation Trust, Manchester

All Listed Sponsors

lead

Entia Ltd

INDUSTRY

NCT03923296 - PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy. | Biotech Hunter | Biotech Hunter